Aeglea BioTherapeutics
program with our platform to enzymes we are designing solutions for a range of rare and high burden diseases our most advanced research program looks to lower cystine levels in patients with cystinuria | Aeglea BioTherapeutics
Deck date
August 2020
Slide
23 of 28
Related slides by other companies
Results
March 2024
Investor Presentation
April 2021
Results
August 2023
Investor Conference
June 2020
Other recent decks by Aeglea BioTherapeutics
Investor Presentation
October 2023
Investor Presentation
October 2023
Investor Presentation
September 2023
Investor Presentation
July 2023
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2023 Slidebook.io